Drug intelligence / Profile preview

Glodent

Development stage: Unknown
Lead developer: Group Pharmaceutical
Modality: Recombinant Proteins and Enzymes, Small Molecules
Administration: Topical

Overview

Glodent is a whitening toothpaste developed by Group Pharmaceutical, primarily marketed in India. It utilizes a non-abrasive, enzymatic whitening mechanism featuring papain and bromelain, which are proteolytic enzymes derived from papaya and pineapple, respectively. These enzymes work by breaking down the protein pellicle on the tooth surface, which helps in removing extrinsic stains without damaging the enamel. The formulation also contains sodium monofluorophosphate to provide fluoride for enamel remineralization and caries prevention, as well as herbal extracts like Meswak and Neem for gum health maintenance.

Brand names: Glodent

Targets

HydroxyapatiteOral plaque bacteria

Beyond the preview

Go deeper on Glodent.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glodent.

Explore the full profile